---
title: "TC BIOPHARM (HOLDINGS) PLC SPON ADS EACH REP 4000 SHS (POST SPLIT) (TCBPY.US) — 財務報表"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/TCBPY.US/norm.md"
symbol: "TCBPY.US"
name: "TC BIOPHARM (HOLDINGS) PLC SPON ADS EACH REP 4000 SHS (POST SPLIT)"
parent: "https://longbridge.com/zh-HK/quote/TCBPY.US.md"
datetime: "2026-03-04T16:28:09.545Z"
locales:
  - [en](https://longbridge.com/en/quote/TCBPY.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/TCBPY.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/TCBPY.US/norm.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/TCBPY.US/norm.md) | [简体中文](https://longbridge.com/zh-CN/quote/TCBPY.US/norm.md)


# TC BIOPHARM (HOLDINGS) PLC SPON ADS EACH REP 4000 SHS (POST SPLIT) (TCBPY.US) — 財務報表

## 損益表 (USD)

| 指標 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -25.31 | -26.99 | -100.78 | - | - |
| ROE | -454.92% | -546.14% | -515.21% | -705.70% | -466.62% |
| 營業收入 | - | - | - | - | - |
| 凈利潤 | -4.29M | -4.58M | -2.51M | -4.19M | -3.99M |
| 營業利潤 | -4.57M | -4.87M | -2.64M | -4.35M | -4.03M |
| 毛利率 | - | - | - | - | - |
| 凈利率 | - | - | - | - | - |
| 利潤含金量 | - | - | - | - | - |

## 資產負債表 (USD)

| 指標 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
| --- | --- | --- | --- | --- | --- |
| 資產與負債 | 10.45M | 11.14M | 8.69M | 9.17M | 11.39M |
| 權益乘數 | 2.77 | 2.77 | 3.43 | 6.72 | 3.33 |
| 每股凈資產 | 5.92 | 6.31 | 102.46 | 85.34 | - |
| 資產周轉率 | - | - | - | - | - |
| 現金及短投 | 1.53M | 1.63M | 1.27M | 1.24M | 3.14M |
| 存貨與應收 | - | - | - | - | - |
| 長期投資 | 2.62M | 2.79M | 2.92M | 3.10M | 3.33M |
| 凈債務 | 356108.00 | 379682.44 | 820658.10 | 942839.48 | -843226.29 |

## 現金流量表 (USD)

| 指標 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
| --- | --- | --- | --- | --- | --- |
| 經營現金流 | -4.66M | -4.97M | -3.45M | -3.04M | -2.36M |
| 投資現金流 | -35650.57 | -38010.65 | -38002.96 | -7089.23 | 5122.19 |
| 融資現金流 | 4.86M | 5.18M | 3.52M | 1.18M | 2.77M |
| 自由現金流 | -2.71M | -4.23M | -2.61M | -1.54M | -2.14M |
| 現金流充裕率 | -17372.24% | -17372.24% | -13104.86% | - | 7619.04% |
| 舉債與償債 | - | - | - | - | - |
| 資本支出 | -26814.46 | -28589.58 | -26360.50 | - | 30919.27 |